Detected ·
T-Therapeutics
$133MSeries B
T-Therapeutics closed an oversubscribed $133M Series B to advance its OpTiMus® TCR therapy platform toward clinical proof-of-concept, with M Ventures joining the syndicate.
- Website
- —
- —
- Amount
- $133 000 000 USD
- Stage
- Series B
- Event
- Funding round
- Detected
- 2026-11-06 20:09:16 UTC
- Signal ID
- 64a27229-18b8-440c-a280-d426a9632ae8
As the API returns it
{
"id": "64a27229-18b8-440c-a280-d426a9632ae8",
"created_at": "2026-11-06T20:09:16.013768Z",
"company_name": "T-Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 133000000,
"funding_currency": "USD",
"funding_stage": "series_b",
"message": "*T-Therapeutics closed an oversubscribed $133M Series B to advance its OpTiMus® TCR therapy platform toward clinical proof-of-concept, with M Ventures joining the syndicate.*"
}